drugset / Trial / NCT00887627

Study to Compare Conivaptan Pharmacokinetics in Subjects With Mild & Moderate Kidney Function Impairment to Subjects With Normal Kidney Function

NCT00887627

Phase 1 Completed 25 enrolled Cumberland Pharmaceuticals
Non-randomizedParallel-groupOpen-label

Summary

A study to compare a conivaptan PK in subjects with mild or moderate kidney function impairment to subjects with normal kidney function after a 48-hour continuous infusion of conivaptan.

Timeline

Start
2009-04
Primary completion
2010-07
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Conivaptan Small molecule Intravenous

Indications